文献速递细菌感染、耐药与抗菌药物

金黄色葡萄球菌菌血症死亡率下降:2139例回顾性队列研究(2007-2015)

Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究在纽约市一家学术医疗中心回顾了2007至2015年间2139例金黄色葡萄球菌菌血症成人患者,按三个时段分析趋势。结果显示MRSA菌血症死亡率无显著变化,而MSSA菌血症死亡率显著下降,且MSSA感染中抗葡萄球菌治疗平均时间缩短,多因素分析显示初始MSSA培养阳性后7天内接受治疗与生存相关。

要点

  • MSSA菌血症死亡率从18%降至13%,MRSA死亡率无显著变化。
  • MSSA感染中抗葡萄球菌治疗平均时间从3.7天缩短至2.2天。
  • 初始MSSA培养阳性后7天内治疗与生存相关。

核心结论

  • MSSA菌血症死亡率下降,与靶向治疗时间缩短相关,提示快速诊断和早期优化治疗可能改善MSSA菌血症结局。

研究设计与样本

  • 回顾性观察性队列研究,纳入纽约市一家学术医疗中心2007年1月1日至2015年12月31日成人金黄色葡萄球菌血流感染患者,共2139例(MSSA 1264例,MRSA 875例),分三组进行趋势分析,所有临床菌株进行spa基因分型。

主要发现

  • MSSA比例上升:组1 55%,组2 59%,组3 63%(P = .03)。
  • MRSA感染死亡率无变化:组1 25%,组2 25%,组3 26%。
  • MSSA感染死亡率显著下降:组1 18%,组2 18%,组3 13%。
  • MSSA感染中抗葡萄球菌治疗平均时间缩短:组1 3.7天,组2 3.5天,组3 2.2天。
  • 多因素分析显示初始MSSA培养阳性后7天内接受抗葡萄球菌治疗与生存相关。

临床怎么用

  • 对MSSA菌血症应尽快启动靶向抗葡萄球菌治疗,初始培养阳性后7天内治疗与生存改善相关。
  • 快速诊断和早期优化治疗可能有助于降低MSSA菌血症死亡率。

局限性

  • 本研究为单中心回顾性观察性队列研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the changing epidemiology of Staphylococcus aureus bacteremia, as well as the variables associated with poor outcomes, can yield insight into potential interventions. METHODS: This study was a retrospective, observational cohort study of adult patients at an academic medical center in New York City who had S. aureus bloodstream infections between 1 January 2007 and 31 December 2015. Participants were divided into 3 periods: group 1 (2007-2009), group 2 (2010-2012), and group 3 (2013-2015) for trend analysis. All clinical strains were genotyped (spa.). The main outcome was 30-day all-cause mortality. RESULTS: There were 1264 episodes of methicillin-susceptible S. aureus (MSSA) and 875 episodes of methicillin-resistant S. aureus (MRSA) bacteremia, with a rising proportion due to MSSA (55% group 1; 59% group 2; 63% group 3; P = .03.) There were no significant changes in average age, gender, Charlson score, and distribution of strain genotypes. Mortality in MRSA infection was unchanged (25% group 1; 25% group 2; 26% group 3), while mortality in MSSA infection significantly declined (18% group 1; 18% group 2; 13% group 3). The average time to antistaphylococcal therapy (AST) in MSSA infection declined during the study (3.7 days group 1; 3.5 group 2; 2.2 group 3). In multivariate analysis, AST within 7 days of initial positive MSSA culture was associated with survival. CONCLUSIONS: Mortality in MSSA bloodstream infection is declining, associated with a decrease in time to targeted therapy. These results emphasize the potential for rapid diagnostics and early optimization of treatment to impact outcomes in MSSA bacteremia.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Austin ED, Sullivan SS, Macesic N, et al. Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015. Clin Infect Dis. 2020. PMID: 31185081. doi:10.1093/cid/ciz498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。